The powerful magnetic fields and radio waves used by MRI scanners appear to affect the concentration and visuospatial awareness of exposed workers.
The powerful magnetic fields and radio waves used by MRI scanners appear to affect the concentration and visuospatial awareness of exposed workers, according to an experimental study published online in the journal Occupational and Environmental Medicine.
Using a double-blind, randomized crossover design, researchers from the Netherlands assessed 31 healthy volunteers who were exposed to low (0.5) and high (1) static magnetic stray field (SMF) of a 7 Tesla (T) MRI scanner. The volunteers were also exposed to a sham environment, with no SMF. The tests were done at one-week intervals, in random order.
After each exposure, the volunteers completed 12 timed cognitive tasks, such as visual tracking and movement, which were chosen to mimic the skills and tasks that a health care professional may have to perform while in the vicinity of a MRI scanner.
The researchers found that among the 30 volunteers who completed the study, there was a significant effect on general functions, such as attention and concentration (varying from 5 percent to 21.1 percent) per Tesla exposure, as well as on visuospatial orientation (46.7 percent per Tesla exposure) compared to the sham.
Non-verbal memory did not seem to be affected by the exposure, but there was a borderline significant drop in verbal memory. Some volunteers experienced physical effects. Twelve complained of a metallic taste, six complained of dizziness, five of headache, and one of nausea.
“The exact implications and mechanisms of these subtle effects in [practice] remain unclear,” the author wrote.
As research continues on providing more powerful scanners to improve imaging, employees may be exposed to more frequent and more powerful static electromagnetic fields. “Further studies are needed to better understand the mechanisms and possible practical safety and health implications of these acute neurocognitive effects,” concluded the authors.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.